Effects of pretreatment with esmolol and lidocaine on injection pain androcuronium-induced withdrawal response

Background/aim: We aimed to compare the effectiveness of esmolol 1 mg/kg and lidocaine 1 mg/kg for injection pain and for the prevention of rocuronium-induced withdrawal response. Materials and methods: We enrolled a total of 81 patients in the study. Patients were randomly assigned to receive either 10 mL of 0.9% NaCl (Group P), esmolol 1 mg/kg (Group E), or lidocaine 1.0 mg/kg (Group L). A subparalyzing dose of rocuronium 0.05 mg/kg was administered to all patients and its effects were recorded. Anesthesia was induced with intravenous propofol and intravenous rocuronium 0.5 mg/kg in all groups. The withdrawal movements of the patient groups were subsequently graded. Results: There was a statistically significant difference in overall incidence of pain in group E and L compared to the placebo group after administrating the subparalyzed dose (no pain response: Group E = 81.5%, Group L = 77.8%, Group P = 14.8%) (P < 0.001). After intravenous administration of an intubating dose of rocuronium, the esmolol group had a significantly lower incidence of withdrawal movement than the other groups (no response: Group E = 81.5%, Group L = 63%, Group P = 22.2%) (P < 0.001). Conclusion: We found that esmolol significantly attenuates rocuronium-induced withdrawal movement and also reduces pain when used at subparalyzing doses.

Effects of pretreatment with esmolol and lidocaine on injection pain androcuronium-induced withdrawal response

Background/aim: We aimed to compare the effectiveness of esmolol 1 mg/kg and lidocaine 1 mg/kg for injection pain and for the prevention of rocuronium-induced withdrawal response. Materials and methods: We enrolled a total of 81 patients in the study. Patients were randomly assigned to receive either 10 mL of 0.9% NaCl (Group P), esmolol 1 mg/kg (Group E), or lidocaine 1.0 mg/kg (Group L). A subparalyzing dose of rocuronium 0.05 mg/kg was administered to all patients and its effects were recorded. Anesthesia was induced with intravenous propofol and intravenous rocuronium 0.5 mg/kg in all groups. The withdrawal movements of the patient groups were subsequently graded. Results: There was a statistically significant difference in overall incidence of pain in group E and L compared to the placebo group after administrating the subparalyzed dose (no pain response: Group E = 81.5%, Group L = 77.8%, Group P = 14.8%) (P < 0.001). After intravenous administration of an intubating dose of rocuronium, the esmolol group had a significantly lower incidence of withdrawal movement than the other groups (no response: Group E = 81.5%, Group L = 63%, Group P = 22.2%) (P < 0.001). Conclusion: We found that esmolol significantly attenuates rocuronium-induced withdrawal movement and also reduces pain when used at subparalyzing doses.

___

  • Kwak HJ, Kim JY, Kim YB, Min SK, Moon BK, Kim JY. Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis. J Anesth 2013; 27: 742–749.
  • Jeon Y, Baek SU, Park SS, Kim SO, Baek WY, Yeo JS. Effect of pretreatment with acetaminophen on withdrawal movements associated with injection of rocuronium: a prospective, randomized, double-blind, placebo controlled study. Korean J Anesthesiol 2010; 59: 13–16.
  • McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs 2010; 70: 1149–1163.
  • Chia YY, Chan MH, Ko NH, Liu K. Role of β-blockade in anaesthesia and postoperative pain management after hysterectomy. Brit J Anaesth 2004; 93: 799–805.
  • Zhang Y, Xiang Y, Liu J. Prevention of pain on injection of rocuronium: a comparison of lidocaine with different doses of parecoxib. J Clin Anesth 2012; 24: 456–459.
  • Choi BI, Choi SH, Shin YS, Lee SJ, Yoon KB, Shin SK, Lee KY. Remifentanil prevents withdrawal movements caused by intravenous injection of rocuronium. Yonsei Med J 2008; 49: 211–216.
  • Lee HJ, Han SJ, Kim H, Lee IO, Kong MH, Kim NS, Lim SH, Lee MK. Antihistamine pretreatment to reduce incidence of withdrawal movement after rocuronium injection. J Korean Med Sci 2009; 24: 879–882.
  • Mencke T, Schreiber JU, Knoll H, Stracke C, Kleinschmidt S, Rensing H, Silomon M. Women report more pain on injection of a precurarization dose of rocuronium: a randomized, prospective, placebo-controlled trial. Acta Anaesth Scand 2004; 48: 1245–1248.
  • Liou JT, Hsu JC, Liu FC, Ching-Wah Sum D, Lui PW. Pretreatment with small-dose ketamine reduces withdrawal movements associated with injection of rocuronium in pediatric patients. Anesth Analg 2003; 97: 1294–1297.
  • Akcaboy ZN, Akcaboy EY, Soyal OB, Turhan G, Gogus N. Can ephedrine pretreatment be effective in alleviating rocuronium injection pain? Med Princ Pract 2012; 21: 323–327.
  • Turan A, Memis D, Karamanlioglu B, Sut N, Pamukcu Z. The prevention of pain from injection of rocuronium by magnesium sulphate, lignocaine, sodium bicarbonate and alfentanil. Anaesth Intens Care 2003; 31: 277–281.
  • Polat R, Aktay M, Ozlü O. The effects of remifentanil, lidocaine, metoclopramide, or ketamine pretreatment on propofol injection pain. Middle East J Anesthesiol 2012; 21: 673–677.
  • Huang YW, Buerkle H, Lee TH, Lu CY, Lin CR, Lin SH, Chou AK, Muhammad R, Yang LC. Effect of pretreatment with ketorolac on propofol injection pain. Acta Anaesth Scand 2002; 46: 1021–1024.
  • Cheong KF, Wong WH. Pain on injection of rocuronium: influence of two doses of lidocaine pretreatment. Brit J Anaesth 2000; 84: 106–107.
  • Akgün Salman E, Titiz L, Akpek E, Arslan G. Pretreatment with a very low dose of intravenous esmolol reduces propofol injection pain. Ağrı 2013; 25: 13–18.
  • Booze RM, Crisostomo EA, Davis JN. Beta-adrenergic receptors in the hippocampal and retrohippocampal regions of rats and guinea pigs: autoradiographic and immunohistochemical studies. Synapse 1993; 13: 206–214.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

The effect of swimming and type of stroke on bone metabolism in competitiveadolescent swimmers: a pilot study

Sinem AKGÜL, Nuray KANBUR, Şükrü Alpan CİNEMRE, Erdem KARABULUT, Orhan DERMAN

VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients

Yung An CHUA, Wan Zaidah ABDULLAH, Zurkurnai YUSOF, Siew Hua GAN

Investigation of the effect of changes in muscle strength in gestational ageupon fear of falling and quality of life

Emrah ATAY, Fatma Başalan İZ

The effects of aspirin, flurbiprofen, and NO-donating acetylsalicylic acid(NCX 4016) on mice models of endotoxic and septic shock

Nadir ULU, Alper Bektaş İSKİT, Cenk SÖKMENSÜER, Mustafa Oğuz GÜÇ

Epidemiology, causative agents, and risk factors affecting humanotomycosis infections

Metwally ABDELAZEEM, Ahmed GAMEA, Hanan MUBARAK, Nessma ELZAWAWY

Evaluation of patency following revision technique ofhigh-velocity arteriovenous fistula

Ümit HALICI, Mehmet Ali KAYGIN, Özgür DAĞ, Ahmet AYDIN, Hüsnü Kamil LİMANDAL, Ümit ARSLAN, Eyüp Serhat ÇALIK, Bilgehan ERKUT

Smoking cessation and the effect of nicotine dependence onrelapse rate in İzmir, Turkey

Özlem PEKEL, Gül ERGÖR, Türkan GÜNAY, Hakan BAYDUR, BERİL CHOUSSEIN, Refik BUDAK, Sinem DOĞANAY

Herbal self-medication use in patients with diabetes mellitus type

Nikola STEFANOVI, Snezana GUBERINIC ZLATKOVIC, Aleksandra DJORDJEVIC CATIC, Radmila RADOVANOVIC VELICKOVIC, Ivana DAMNJANOVIC, Dusanka KITIC

Multidrug resistance and integron carriage in clinical isolates ofPseudomonas aeruginosa in Tehran, Iran

Somayeh Moazami GOUDARZI, Fereshteh EFTEKHAR

Herbal self-medication use in patients with diabetes mellitus type 2

İvana DAMNJANOVIC, Dusanka KITIC, Nikola STEFANOVIC, Snezana ZLATKOVIC-GUBERINIC, Aleksandra CATIC-DJORDJEVIC, Radmila VELICKOVIC-RADOVANOVIC